SCHEMBL4839714

SCHEMBL4839714

COc1ccc2c(c1)C(=CC(=O)c1ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc1)NC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 10/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
PLAT P00750 1/20 0.45
ATM Q13315 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
PGR P06401 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839698 1.00 PLAU (0.48) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4843829 0.92 TCF4 (0.45) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4843837 0.92 TCF4 (0.45) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4844743 0.90 PLAU (0.48) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4844730 0.90 PLAU (0.48) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4844353 0.90 LMNA (0.44) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4844339 0.90 LMNA (0.44) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4834513 0.88 PPIA (0.47) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4834505 0.88 PPIA (0.47) PLAUSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL4840956 0.87 SMN1; SMN2 (0.43) PLAUSMN1; SMN2LMNAALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 PLAU 1618/4885SMN1; SMN2 144/4885LMNA 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.